World Bulletin / News Desk
People using a common class of antidepressants may have slightly increased odds of suffering bleeding in the brain - though the risk is still very small, according to a Canadian study looking at more than 500,000 people.
The antidepressants are known as selective serotonin reuptake inhibitors (SSRIs) and include widely used drugs like fluoxetine (Prozac), sertraline (Zoloft), citalopram (Celexa) and paroxetine (Paxil.)
The SSRIs have been linked to a risk of stomach bleeding, but studies have come to conflicting findings on whether SSRI users have any higher risk of hemorrhagic strokes, which happen when there is bleeding in or around the brain.
For the study, which appeared in the journal Neurology, researchers pooled the findings from 16 past studies involving more than 500,000 people who were on SSRIs or not.
Overall, antidepressant users were about 40 to 50 percent more likely to suffer bleeding in or around the brain.
But while those numbers might sound big, the risks to any one person would be "extremely low," said lead researcher Daniel Hackam, an associate professor of medicine at Western University in London, Ontario, Canada.
Based on these figures, he said, there would be one brain hemorrhage for every 10,000 people using an SSRI over one year.
What's more, the findings do not prove that the antidepressants directly cause brain bleeds. It's possible, Hackham said, that SSRI users are "sicker" than non-users or have habits that put them at greater stroke risk.
The researchers tried to account for those factors in their calculations, but some of the studies they analyzed lacked key information, such as peoples's smoking and drinking habits, and whether they had diabetes.
"We can't infer cause and effect from this," Hackam said.
On the other hand, there are reasons to believe it's the medications themselves. For one, the hemorrhage risk seemed greatest in the first months after people started using an SSRI.
There's also a biological argument. SSRIs seem to make it harder for blood cells called platelets to clump together and form clots - and there can be a big drop in a person's platelet functions in the first weeks after starting an SSRI, he said.
Still, he stressed that people on the antidepressants should not be alarmed.
"I think that overall, these medications are quite safe," he added.
But people who are already at increased risk of a brain hemorrhage may need to be careful. That includes people who have had a brain bleed in the past, or are on medications that reduce blood clotting.
A deal between the richest nations in the world has been seen as unlikely, as OECD seeks to phase out export credits.
Soon more than 1 billion consumers in developing nations will be able to buy their first air conditioner, increasing energy demand which will impact global warming
The European Union has given new authorization for 10 new types of genetically modified crops have been approved for a 10 year use for human consumption and animal feed.
Guinea's President Alpha Conde announced new emergency measures in Ebola fight on Saturday
'Meetings happened. Action didn’t,' says Medecins Sans Frontieres report.
WHO said that on many levels, the world is better prepared now than ever before for aflu pandemic
Myanmar health officals say an outbreak of H5N1 bird flu in Mandalay
Tokyo Electric said it has been aware since last spring that radiation levels in water running in one of the plant gutters rise when it rains
Safe drinking water is available at about one-third of the level it was before the conflict erupted nearly five years ago, and supplies are cut-off to punish civilians at times
Elephants in Angola, which suffered decades of civil war, have been observed avoiding heavily-mined areas, suggesting their trunks were warning them to stay away.
Favipiravir halved death rate among some to 15 pct, but WHO says more research required on drug
The first medicine containing stem cells to treat a rare condition caused by burns to the eye has approved.
940 parasite samplescollected at 55 malaria treatment centres across Myanmar and its border regions. They found that almost 40 percent of the samples had mutations in their so-called kelch gene, K13 -- a known genetic signal of artemisinin drug resistance.
Yaws is known to be prevalent in 12 countries in areas where people have little access to healthcare, mainly in West and Central Africa, Asia and the Pacific Islands.
In the past few years, Nepal has seen the numbers of endangered species, such as the Royal Bengal tiger or the one-horned rhino, rise.
The investment would represent as little as 0.1 percent of current national health spending of the low and middle-income countries affected by NTD.